Kiniksa Pharmaceuticals International, plc KNSA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 41.25 | 84.95 | 87.05 | 0.18 | 19,768 | 14 |
| 2025Q3 | 38.83 | 88.45 | 600.75 | 0.23 | 24,021 | 18 |
| 2025Q2 | 27.67 | 88.12 | 0.23 | 20,160 | 18 | |
| 2025Q1 | 22.21 | 85.27 | 0.11 | 13,272 | 9 | |
| 2024Q4 | 19.78 | 113.66 | -0.12 | -19,299 | -9 | |
| 2024Q3 | 24.99 | 134.12 | -0.17 | -9,658 | -13 | |
| 2024Q2 | 18.67 | -5.08 | 153.12 | -0.06 | -117 | -4 |
| 2024Q1 | 19.73 | 115.87 | 98.92 | -0.25 | -16,542 | -18 |
| 2023Q4 | 17.54 | 3.31 | 0.36 | 81 | 25 | |
| 2023Q3 | 17.37 | 128.57 | 5.27 | -0.20 | -10,927 | -14 |
| 2023Q2 | 14.08 | 254.56 | 8.51 | 0.22 | -3,154 | 15 |
| 2023Q1 | 10.76 | 119.56 | 3.81 | -0.18 | -11,196 | -12 |
| 2022Q4 | 14.98 | 88.39 | 7.31 | 0.05 | 6,047 | 4 |
| 2022Q3 | 12.84 | 99.31 | 3.20 | 46,413 | 224 | |
| 2022Q2 | 9.69 | 100.53 | -0.29 | -19,368 | -20 | |
| 2022Q1 | 9.94 | 100.15 | -0.36 | -23,319 | -25 | |
| 2021Q4 | 11.77 | 100.21 | -0.52 | -36,131 | -36 | |
| 2021Q3 | 11.39 | 100.02 | -0.45 | -30,667 | -31 | |
| 2021Q2 | 13.93 | 100.01 | -0.61 | -40,555 | -42 | |
| 2021Q1 | 18.51 | 100.02 | -0.72 | -49,283 | -49 |